TY  - JOUR
T1  - COverage being questioned?
AU  - Mitka M
Y1  - 2010/10/13
N1  - 10.1001/jama.2010.1417
JO  - JAMA
SP  - 1546
EP  - 1546
VL  - 304
IS  - 14
N2  - 
CMS announced on August 31 that it would hold a meeting November 17 regarding on-label and off-label use of autologous cellular immunotherapy treatment of prostate cancer.

SN  - 0098-7484
M3  - doi: 10.1001/jama.2010.1417
UR  - http://dx.doi.org/10.1001/jama.2010.1417
ER  -